Skip to main content
. 2018 Feb 25;2018(2):CD004982. doi: 10.1002/14651858.CD004982.pub6

5.2. Analysis.

5.2

Comparison 5 Thirty‐day prophylactic low molecular weight heparin (LMWH) versus 30‐day intermediate LMWH, Outcome 2 Venous thromboembolism 3‐month follow‐up.